You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 30, 2024

CLINICAL TRIALS PROFILE FOR KYNMOBI


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for KYNMOBI

Trial ID Title Status Sponsor Phase Start Date Summary
NCT05529095 ↗ Sublingual Apomorphine in Refractory Restless Legs Syndrome Not yet recruiting Sunovion Phase 4 2022-09-01 This is an open label, short placebo-controlled trial in Restless Legs Syndrome (RLS) patients inadequately treated with standard therapy. Investigators hypothesize that the study drug, sublingual apomorphine (Kynmobi), may improve RLS breakthrough symptoms. This study is designed to determine if sublingual apomorphine improves breakthrough symptoms in RLS patients, in addition to subjective responses.
NCT05529095 ↗ Sublingual Apomorphine in Refractory Restless Legs Syndrome Not yet recruiting William Ondo, MD Phase 4 2022-09-01 This is an open label, short placebo-controlled trial in Restless Legs Syndrome (RLS) patients inadequately treated with standard therapy. Investigators hypothesize that the study drug, sublingual apomorphine (Kynmobi), may improve RLS breakthrough symptoms. This study is designed to determine if sublingual apomorphine improves breakthrough symptoms in RLS patients, in addition to subjective responses.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for KYNMOBI

Condition Name

Condition Name for KYNMOBI
Intervention Trials
Restless Legs Syndrome 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for KYNMOBI
Intervention Trials
Syndrome 1
Restless Legs Syndrome 1
Psychomotor Agitation 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for KYNMOBI

Trials by Country

Trials by Country for KYNMOBI
Location Trials
United States 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for KYNMOBI
Location Trials
Texas 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for KYNMOBI

Clinical Trial Phase

Clinical Trial Phase for KYNMOBI
Clinical Trial Phase Trials
Phase 4 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for KYNMOBI
Clinical Trial Phase Trials
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for KYNMOBI

Sponsor Name

Sponsor Name for KYNMOBI
Sponsor Trials
Sunovion 1
William Ondo, MD 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for KYNMOBI
Sponsor Trials
Industry 1
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.